GlassScriptPhysician profile
Clark Wells Griffith
NPI 1588666242
$3,084.43
in general payments reported to CMS, 2019-2025
35 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $124 · 2021: $162 · 2022: $552 · 2023: $745 · 2024: $616 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,418 · Education: $258 · Gift: $4.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,417.92 |
| Education | $257.89 |
| Gift | $4.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $365.52 | 2019-2023 | |
| Astellas Pharma US INC | $289.18 | 2023-2025 | Veozah, Myrbetriq |
| Fisher Scientific Company L.L.C. | $257.89 | 2024 | Procalcitonin |
| Exeltis, USA INC. | $240.59 | 2019-2025 | Slynd |
| Abbvie INC. | $186.03 | 2019-2023 | |
| Organon LLC | $180.79 | 2022-2025 | Nexplanon, Nuvaring |
| Merck Sharp & Dohme LLC | $173.25 | 2019-2020 | |
| Pfizer INC. | $167.91 | 2019-2025 | |
| Gynesonics, INC. | $135.69 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $111.24 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $108.79 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.79 | 2019-2025 | |
| Millicent US INC | $97.66 | 2022-2025 | Intrarosa, Femring |
| Amgen INC. | $74.01 | 2019-2021 | |
| Minerva Surgical, INC | $69.13 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $62.07 | 2019 | |
| Aspira Women'S Health INC | $55.66 | 2019-2020 | |
| Shield Therapeutics INC | $43.95 | 2024-2025 | |
| Integra Lifesciences Corporation | $34.61 | 2023-2025 | Codman Certas, Duraseal Exact Spinal Sealant System, Codman Hakim |
| Channel Medsystems, INC. | $33.05 | 2023 | |
| Therapeuticsmd, INC. | $32.59 | 2019-2022 | |
| Coopersurgical, INC. | $31.34 | 2022-2025 | |
| Exact Sciences Corporation | $30.42 | 2023-2025 | Cologuard Collection Kit |
| Ethicon US, LLC | $28.38 | 2019-2023 | |
| Innovation Technologies INC | $24.37 | 2023 | Irrisept |
| Myovant Sciences INC. | $21.69 | 2022 | |
| Hologic Sales and Service, LLC | $20.22 | 2025 | Myosure Tissue Removal Device, Novasure, Omni Hysteroscope |
| Olympus America INC. | $18.49 | 2023 | Olympus, 4k Cable 8.5m |
| Meditrina | $16.04 | 2022 | |
| Lupin INC. | $14.11 | 2019 | |
| Avion Pharmaceuticals | $13.84 | 2019 | |
| Sage Therapeutics, LLC | $13.80 | 2025 | Zurzuvae |
| Duchesnay USA Incorporated | $13.18 | 2019 | |
| Caldera Medical, INC | $13.15 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.